Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels

Authors

Keywords

Journal

Volume 152, Issue 3, Pages 386-395

Publisher

Wiley

Online

2007-08-16

DOI

10.1038/sj.bjp.0707414

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started